Skip to main content
. 2021 May 25;14(6):504. doi: 10.3390/ph14060504

Figure 4.

Figure 4

Myo-inositol participates in the signaling cascade of insulin. Particularly, it is involved in the releasing of vesicles containing GLUT-4. GLUT-4 promotes the absorption of glucose from the bloodstream, reducing systemic glycemia. Reduced glycemia is then recognized from pancreatic cells as a stimulus that inhibits insulin release. Therefore, myo-ins administration leads to reduced levels of glucose and insulin, preventing the onset of GDM.